MYH9 and nonpapillary renal cell carcinoma: CCK8 and colony formation assay revealed that MYH9 knockdown ccRCC cells presented an increased sensitivity to sunitinib treatment compared with control group, while activation of AKT remarkably restored sunitinib resistance (Fig. 7a, b).